VM (nerve agent)
This article needs additional citations for verification. (March 2018) (Learn how and when to remove this template message)
|Systematic IUPAC name
S-[2-(Diethylamino)ethyl] O-ethyl methylphosphonothioate
3D model (JSmol)
|Molar mass||239.32 g/mol|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|what is ?)(|
Like most of the agents in the V-series (with the exception of VX), VM has not been extensively studied outside of military science. Little is known about this chemical compound other than its chemical formula.
It is commonly theorized that the so-called "second-generation" V series agents came from a Cold War era Russian chemical weapons development program. They may have been developed sometime between 1950 and 1990. They have similar lethal dose levels to VX (between 10 and 50 mg) and have similar symptoms and method of action to other nerve agents that act on cholinesterase. The treatment remains the same, but the window for effectively treating second generation V series seizures is shorter. In addition to the standard seizures, some of the second generation V series agents are known to cause comas.